ERBB2 and breast cancer: We used data from US population-based Surveillance Epidemiology and End Results (SEER) cancer registries to examine trends in the incidence of breast cancer by age and racial/ethnic groups from 2010 to 2016 for 4 molecular subtypes, defined by joint expression of hormone receptor and ERBB2 status.